Japan Dry Eye Syndrome Market Size US$ 173.5 Million by 2028, With Growth Rate (CAGR) 4.1%

 IMARC Group, a leading market research company, has recently releases report titled “Japan Dry Eye Syndrome Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the Japan dry eye syndromes share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. 

How Big is the Japan Dry Eye Syndrome Market?

The Japan dry eye syndrome market size reached US$ 134.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 173.5 Million by 2028, exhibiting a growth rate (CAGR) of 4.1% during 2023-2028.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/japan-dry-eye-syndrome-market/requestsample

Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is a medical condition arising from the lack of adequate quantity or quality of natural tears to offer sufficient moisture or lubrication to the eyes. Some commonly known symptoms of dry eye syndrome include redness, discomfort, pain, soreness, sensitivity to light, itching, aching, and burning sensation in the eye. It can be caused owing to allergies, smoking, hormone replacement therapies, vitamin A deficiency, computer use, laser surgeries, and autoimmune diseases. However, it can be treated with protective eyewear and wraparound sunglasses, artificial tears, medications, lacrimal plugs, and several surgical procedures.

What are the growth prospects and trends in the Japan dry eye syndrome industry?

The market is primarily driven by the growing exposure to digital screens due to the rising use of smartphones and computers. In addition, the increasing prevalence of several medical conditions, such as Sjogren's syndrome, lupus, scleroderma, rheumatoid arthritis, and thyroid disorders, are contributing to the market growth. 

Moreover, the increasing number of individuals undergoing LASIK surgeries represents another major growth-inducing factor. Besides this, the growing geriatric population that is prone to developing various medical conditions and the widespread adoption of hyaluronic acid for retaining moisture and treating dry eye syndrome is providing a positive thrust to the market growth. 

Furthermore, the launch of novel treatment options and the introduction of functional visual acuity meter devices to measure changes in continuous visual acuity over time is also creating a favorable market outlook across the country. 

Buy This Report: https://www.imarcgroup.com/checkout?id=4938&method=7

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Disease Type:

• Evaporative Dry Eye Syndrome

• Aqueous Dry Eye Syndrome

Breakup by Drug Type:

• Anti-inflammatory Drugs

• Lubricant Eye Drops

• Autologous Serum Eye Drops

Breakup by Product:

• Liquid Drops

• Gel

• Liquid Wipes

• Eye Ointment

• Others

Breakup by Distribution Channel:

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Breakup by Region:

• Kanto Region

• Kinki Region

• Central/ Chubu Region

• Kyushu-Okinawa Region

• Tohoku Region

• Chugoku Region

• Hokkaido Region

• Shikoku Region

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4938&flag=C

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the companies operating in the market.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/